SG11202006215TA - Peptide immunogens and formulations thereof targeting membrane-bound ige for treatment of ige mediated allergic diseases - Google Patents

Peptide immunogens and formulations thereof targeting membrane-bound ige for treatment of ige mediated allergic diseases

Info

Publication number
SG11202006215TA
SG11202006215TA SG11202006215TA SG11202006215TA SG11202006215TA SG 11202006215T A SG11202006215T A SG 11202006215TA SG 11202006215T A SG11202006215T A SG 11202006215TA SG 11202006215T A SG11202006215T A SG 11202006215TA SG 11202006215T A SG11202006215T A SG 11202006215TA
Authority
SG
Singapore
Prior art keywords
ige
formulations
treatment
allergic diseases
peptide immunogens
Prior art date
Application number
SG11202006215TA
Other languages
English (en)
Inventor
Chang Yi Wang
Feng Lin
Jiun Bo Chen
Original Assignee
United Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Biomedical Inc filed Critical United Biomedical Inc
Publication of SG11202006215TA publication Critical patent/SG11202006215TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6075—Viral proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
SG11202006215TA 2017-12-31 2017-12-31 Peptide immunogens and formulations thereof targeting membrane-bound ige for treatment of ige mediated allergic diseases SG11202006215TA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2017/069174 WO2019133024A1 (en) 2017-12-31 2017-12-31 Peptide immunogens and formulations thereof targeting membrane-bound ige for treatment of ige mediated allergic diseases

Publications (1)

Publication Number Publication Date
SG11202006215TA true SG11202006215TA (en) 2020-07-29

Family

ID=67068075

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202006215TA SG11202006215TA (en) 2017-12-31 2017-12-31 Peptide immunogens and formulations thereof targeting membrane-bound ige for treatment of ige mediated allergic diseases

Country Status (13)

Country Link
US (1) US20230270848A1 (ja)
EP (1) EP3731934A1 (ja)
JP (1) JP7239203B2 (ja)
KR (1) KR20200115522A (ja)
CN (1) CN111565801B (ja)
AU (1) AU2017445171A1 (ja)
BR (1) BR112020013352A2 (ja)
CA (1) CA3087036A1 (ja)
MX (1) MX2020006937A (ja)
RU (1) RU2769983C2 (ja)
SG (1) SG11202006215TA (ja)
TW (1) TWI804553B (ja)
WO (1) WO2019133024A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2022009144A (es) * 2020-01-23 2022-08-22 United Biomedical Inc Inmunogenos peptidicos dirigidos al peptido activador de adenilato ciclasa hipofisaria (pacap) y formulaciones de los mismos para la prevencion y el tratamiento de migra?a.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4012095A (en) * 1994-10-25 1996-05-15 United Biomedical Inc. Synthetic ige membrane anchor peptide immunogens for the treatment of allergy
TWI227241B (en) * 1998-06-20 2005-02-01 United Biomedical Inc IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate
WO2002020038A2 (en) * 2000-09-06 2002-03-14 Pharmexa A/S Method for down-regulating ige
US6906169B2 (en) * 2001-05-25 2005-06-14 United Biomedical, Inc. Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
AU2003243663A1 (en) * 2002-06-20 2004-01-06 The Trustees Of The University Of Pennsylvania Vaccines for suppressing ige-mediated allergic disease and methods for using the same
MY183134A (en) * 2009-02-25 2021-02-15 Academia Sinica Anti-cemx antibodies capable of binding to human mlge on b lymphocytes
US9102752B2 (en) * 2013-03-15 2015-08-11 United Biomedical, Inc. Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type

Also Published As

Publication number Publication date
CN111565801B (zh) 2023-11-10
EP3731934A1 (en) 2020-11-04
US20230270848A1 (en) 2023-08-31
WO2019133024A1 (en) 2019-07-04
TW201930346A (zh) 2019-08-01
CN111565801A (zh) 2020-08-21
JP7239203B2 (ja) 2023-03-14
JP2021515744A (ja) 2021-06-24
CA3087036A1 (en) 2019-07-04
MX2020006937A (es) 2020-10-05
BR112020013352A2 (pt) 2020-12-01
RU2020125383A (ru) 2022-01-31
RU2020125383A3 (ja) 2022-01-31
TWI804553B (zh) 2023-06-11
KR20200115522A (ko) 2020-10-07
AU2017445171A1 (en) 2020-08-13
RU2769983C2 (ru) 2022-04-12

Similar Documents

Publication Publication Date Title
EP3349783C0 (en) COMPOSITIONS AND METHODS ASSOCIATED WITH THE TREATMENT OF DISEASES
HK1246712A1 (zh) 神經刺激治療疾病及病症
IL271274A (en) Methods and compositions for inducing mast cell toxicity using human gamma-delta t-cells
IL262608A (en) Combined treatment of eye disorders and inflammatory diseases
IL267210A (en) Amino acid compounds and methods for treating muscle diseases and disorders
ZA201908616B (en) Formulations for treatment of post-traumatic stress disorder
IL269901B (en) Pharmaceutical compounds and methods of treating cardiovascular diseases
ZA201903003B (en) Treatment of neurological diseases
IL264070A (en) Methods and preparations for the treatment of disorders and diseases involving rdh12
EP3713553A4 (en) COMPOSITIONS AND METHODS OF TREATMENT OF EYE DISEASES
IL259710A (en) Preparations and methods for the treatment of Davidson's disease (microvillus inclusion disease) and related diseases
PL3200828T3 (pl) Kompozycje donosowe do leczenia chorób i zaburzeń neurologicznych i neurodegeneracyjnych
EP3468540A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHOD FOR TREATING PAIN
EP3606522C0 (en) NOVEL TREATMENT OF MITOCHONDRIAL DISEASES
GB201714307D0 (en) Treatment of neurodegenerative diseases
SG11202006215TA (en) Peptide immunogens and formulations thereof targeting membrane-bound ige for treatment of ige mediated allergic diseases
PL3515409T3 (pl) Kompleks i kompozycje do leczenia chorób okulistycznych i dermatologicznych
EP3402511A4 (en) COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
EP3534932A4 (en) TREATMENT OF DISEASES ASSOCIATED WITH IGFB3 AND ITS RECEPTOR
EP3500591A4 (en) COMPOSITIONS AND METHODS FOR TREATING BONE-ASSOCIATED DISEASES
GB201714311D0 (en) Treatment of neurodegenerative diseases
GB201714303D0 (en) Treatment of neurodegenerative diseases
KR20180085033A (ko) 피부 질환 치료용 약학적 제형 및 이의 제조 방법
EP3367982A4 (en) DEVICES AND METHODS FOR TREATING OCCULAR DISORDERS BY ADMINISTERING THERAPEUTIC NUCLEIC ACIDS
EP3335141A4 (en) PERSONALIZED TREATMENT OF DISEASES AND DISORDERS